View |
|
BRP-040-10
|
Enoxaparin sodium
|
Enoxden
|
6000 IU anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Limited
|
India
|
-
|
26 October 2021
|
09 December 2025
|
View |
|
DRP-4070-12
|
Fenofibrate
|
None
|
200 mg
|
Capsule
|
Lipid Modifying Agent (Fibrate)
|
XL Laboratories Pvt. Ltd.
|
India
|
Renewal
|
20 April 2022
|
19 October 2027
|
View |
|
DRP-7920-01
|
Levofloxacin (as hemihydrate)
|
Levoxina
|
5 mg/mL (500 mg/100 mL)
|
Solution for IV Infusion
|
-
|
Eurolife Healthcare Pvt. Ltd.
|
India
|
-
|
26 October 2021
|
25 July 2026
|
View |
|
DRHR-530
|
Povidone-Iodine
|
None
|
7.50%
|
Solution
|
Antiseptic / Disinfectant
|
J. CHEMIE LABORATORIES, INC.
|
Philippines
|
Automatic Renewal
|
25 October 2021
|
21 September 2026
|
View |
|
DRP-4072-08
|
Cefixime (as trihydrate)
|
Fixxx
|
200 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Zim Laboratories Limited
|
India
|
Renewal
|
08 April 2022
|
24 October 2027
|
View |
|
DRP-6459-02
|
Cefuroxime (as Axetil)
|
Educef
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Medley Pharmaceuticals Limited
|
India
|
Renewal
|
20 December 2023
|
24 February 2029
|
View |
|
DRP-8501
|
Ranitidine Hydrochloride
|
Ranirex
|
25 mg/mL (50 mg/2 mL)
|
Solution for Injection (IM/IV)
|
H2-Receptor Antagonist
|
Jiangxi Xierkangtai Pharmaceutical Co., Ltd.
|
China
|
-
|
22 October 2021
|
15 May 2026
|
View |
|
DRP-9957
|
Bortezomib
|
Mibor
|
2mg
|
Powder for Solution for Injection (IV)
|
Antineoplastic
|
Celon Laboratories Limited
|
India
|
Automatic Renewal
|
22 October 2021
|
22 November 2026
|
View |
DRP-10469_PI_01.pdf
|
DRP-10469
|
Ceftriaxone (as sodium)
|
Ceftrex
|
1 g
|
Powder for Injection (I.M./I.V.)
|
CEPHALOSPORIN (THIRD GENERATION)
|
United Biotech Pvt. Limited
|
India
|
-
|
22 October 2021
|
19 March 2027
|
View |
|
DRP-5053-02
|
Cefuroxime (As Axetil)
|
Cefupak
|
125mg/5mL
|
Powder For Suspension
|
Antibaterial (Cephalosporin)
|
Opal Laboratories (Pvt) Ltd
|
Pakistan
|
Automatic Renewal
|
22 October 2021
|
30 September 2026
|
View |
|
DRP-10570
|
Anastrazole
|
Scitrozole
|
1 mg
|
Film-Coated Tablet
|
-
|
Intas Pharmaceuticals Limited
|
India
|
-
|
19 October 2021
|
19 September 2026
|
View |
|
BRP-041-08
|
Enoxaparin sodium
|
Enoxden
|
4000 IU Anti-Factor Xa (Equivalent to 40 mg) / 0.4 mL
|
Solution for Injection (SC)
|
Anticoagulant
|
Brawn Laboratories Ltd.
|
India
|
Initial (Revalidation) (Correction)
|
02 August 2023
|
09 December 2025
|
View |
|
DRP-4060-02
|
Pantoprazole (as Sodium Sesquihydrate)
|
Pantozar
|
40 mg
|
Lyophilized Powder for Injection (I.M. / I.V.)
|
Proton Pump Inhibitor
|
Aristopharma Ltd.
|
Bangladesh
|
Renewal
|
31 March 2022
|
22 February 2027
|
View |
|
DRP-6053-02
|
Ceftazidime
|
Onetazid
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Brawn Laboratories Limited
|
India
|
Renewal
|
29 June 2024
|
13 May 2030
|
View |
|
DRP-9156-01
|
Diosmin + Hesperidin
|
None
|
450 mg/50 mg
|
Film-Coated Tablet
|
Vasoprotective
|
Stallion Laboratories Pvt. Ltd.
|
India
|
-
|
15 October 2021
|
20 May 2026
|
View |
|
DRP-10551
|
Azithromycin (as Dihydrate)
|
Azik
|
500 mg
|
Film-Coated Tablet
|
-
|
Kusum Healthcare Private Limited
|
India
|
-
|
15 October 2021
|
13 November 2026
|
View |
|
DRP-6569-01
|
Isotretinoin
|
Karakleen
|
10 mg
|
Softgel Capsule
|
Anti-acne
|
Phil Inter Pharma Co., Ltd. (Plant 1)
|
Vietnam
|
Renewal
|
13 January 2023
|
15 November 2028
|
View |
|
DRP-8348-01
|
Propranolol hydrochloride
|
Propravest
|
40 mg
|
Tablet
|
Non-selective Beta-adrenoceptor Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
16 April 2024
|
20 August 2029
|
View |
|
DRP-9244-03
|
Salbutamol (as sulfate)
|
Bettervent
|
1 mg/mL (2.5mg/2.5mL)
|
Solution for Inhalation
|
Bronchodilator (Selective beta-2-adrenoceptor agonist)
|
Legency Remedies Pvt. Ltd
|
India
|
-
|
13 October 2021
|
09 July 2025
|
View |
|
DRP-5659-02
|
Metformin Hydrochloride
|
None
|
500 mg
|
Extended-Release Tablet
|
Oral Hypoglycemic
|
Ipca Laboratories Ltd.
|
India
|
Renewal
|
20 May 2022
|
21 May 2027
|